Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

CEO Appointment and Board Changes

2 Dec 2009 11:42

RNS Number : 4586D
Ovoca Gold PLC
02 December 2009
Β 

Ovoca Gold plcΒ ("Ovoca" orΒ the "Company")

CEO Appointment andΒ Board ChangesΒ 

OvocaΒ is pleased to announce that Tim McCutcheon has been named CEO effective immediately. Tim has been a director of Ovoca since January 2009. Mikhail Mogutov, will step down as CEO and becomeΒ ExecutiveΒ Chairman, while the current Chairman Leonid Skoptsov will retain his position on the Board as a non-executive director.Β 

Tim has lived and worked inΒ RussiaΒ and theΒ Commonwealth of Independent StatesΒ since 1994. Prior toΒ working inΒ Ovoca, Tim worked in multiple financial institutionsΒ such as Bear Stearns, Aton Capital and Pioneer InvestmentsΒ as an award-winning metals and mining sector analyst and as an investment banker.Β Tim was one of the first analysts inΒ RussiaΒ to write about its gold mining sector and he has advised numerousΒ international gold miningΒ companies on M&A,Β business development, and Russian business practices.Β 

Tim has a BA and MBA fromΒ Columbia University,Β New York,Β USA. He lives inΒ Moscow,Β RussiaΒ and speaks fluent Russian.

Mr. McCutcheonΒ commentedΒ "Given the recent surge in the gold price and increasing interest in the gold mining sector from investors globally,Β I believeΒ now is a particularly fortuitous time to lead a gold mining company.Β It is clear that investors haveΒ been patient with the CompanyΒ as it has re-grouped after the sale of Goltsovoye. I intend to rewardΒ shareholdersΒ for their patience by focusing onΒ long term, sustainableΒ shareholder value.Β IΒ look forward to advancing Ovoca and putting its human and capital resources to work."

Mr. Mogutov comments "I am pleased that we were able to attract someone of Tim'sΒ calibreΒ to lead Ovoca.Β Tim is set to quickly form a wider management team,Β look toΒ acquire new assets and to vigorously advance the company. It has been almost a year since Ovoca sold its core asset Goltsovoye.Β The Company hasΒ cashΒ andΒ technical expertise, and with Tim's appointment we now have a leader to tie everything together to make a vibrant, successful company.

I will take over my previous position as Chairman and would like to thank Mr. Skoptsov for his work in that capacity."Β 

For further information please visit www.ovocagold.com or contact:

Ovoca Gold plc

Timothy McCutcheon +7 495 916 6029Β tim.mccutcheon@ovocagold.com

Mr Danesh Varma, CFO +44 207 653 9881Β danesh.varma@ovocagold.com

DavyΒ 

John FrainΒ +353 1 679 6363

End

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOADGMGZMZGGLZM
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.